In vivo, IT CMP-001 extended the survival of Balb/c mice bearing A20 lymphoma, which constitutively expresses PD-L1 [161], and regression of both injected and non-injected tumors was dependent on whether mice could produce anti-Qβ antibody and whether CD4+ or CD8+ T cells existed [160]. Here, CD8A is linked to lymphoma.